Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for preparing pitavastatin calcium epoxy impurity and nitrogen oxide impurity

A technology of pitavastatin calcium and impurities, which is applied in the field of preparation of pitavastatin calcium epoxy impurities and nitrogen oxide impurities, can solve the problems such as the preparation method of pitavastatin calcium epoxy impurities and nitrogen oxygen impurities that have not been reported in the literature, and achieve The effect of reasonable route design, high impurity purity and simple preparation method

Inactive Publication Date: 2018-12-18
SHANDONG QIDU PHARMA
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The research on pitavastatin calcium oxide impurities is of great significance to improve the quality of pitavastatin calcium raw materials, but there is no literature report on the preparation method of pitavastatin calcium epoxy impurities and nitrogen oxide impurities

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing pitavastatin calcium epoxy impurity and nitrogen oxide impurity
  • Method for preparing pitavastatin calcium epoxy impurity and nitrogen oxide impurity
  • Method for preparing pitavastatin calcium epoxy impurity and nitrogen oxide impurity

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] Add 30ml of chloroform, 4.41g of pitavastatin calcium, and 2.10g of trifluoroacetic anhydride into a 100ml single-necked flask, stir, cool down to 0°C, dissolve 2.76g of carbamide peroxide in 10ml of ethanol, add dropwise at 0°C, add dropwise After completion, keep the reaction at 0°C to 5°C for 5h. TLC detects that the reaction is complete, and 20 ml of saturated Na 2 S 2 o 3 solution, the organic layer was washed with saturated NaCl solution (20ml*3), the organic layer was dried with anhydrous magnesium sulfate, filtered, the filtrate was concentrated under reduced pressure, and separated by column chromatography [eluent: dichloromethane: methanol: glacial acetic acid = 30 :1:1], 1.65g of white solid was obtained, that is, compound 2 (epoxy impurity), the yield was 37.8%, and the liquid phase purity was 99.5%.

[0039] 1 H NMR (400MHz, d-DMSO) δ12.12(s,1H), 7.84(d,1H), 7.64(dt,1H), 7.127.48(m,6H), 4.75(d,1H), 4.49( d,1H), 4.40(s,1H), 4.33(m,1H), 3.94(s,1H), 3.90(...

Embodiment 2

[0043] Add 20ml of absolute ethanol, 4.41g of pitavastatin calcium, and 2.96g of phthalic anhydride into a 100ml single-necked flask, stir, cool down to 0°C, dissolve 3.68g of carbamide peroxide in 10ml of absolute ethanol, and add dropwise at 0°C After the dropwise addition, keep the reaction at 0°C to 5°C for 20h. TLC detects that the reaction is complete, and first adds 50ml of dichloromethane to the reaction solution, then adds 20ml of saturated Na 2 S 2 o 3 solution, the organic layer was washed with saturated NaCl solution (20ml*3), the organic layer was dried with anhydrous magnesium sulfate, filtered, the filtrate was concentrated under reduced pressure, and separated by column chromatography [eluent: dichloromethane: methanol: glacial acetic acid = 30 :1:1] to obtain 1.55 g of white solid, namely compound 2, with a yield of 35.5% and a liquid phase purity of 98.7%.

[0044] The residue was further separated by column chromatography [eluent: dichloromethane: methano...

Embodiment 3

[0046] Add 10ml dimethyl sulfoxide and 10ml N,N-dimethylformamide, 4.41g pitavastatin calcium, 1.13g benzoic anhydride to a 100ml single-necked flask, stir, cool to 0°C, dissolve 0.92g urea peroxide in Add dropwise to 10ml of N,N-dimethylsulfoxide at 0°C. After the dropwise addition is complete, raise the temperature and control the temperature at 55°C to 60°C for 0.5h. TLC detects that the reaction is completed, and 50ml of dichloromethane is added to the reaction solution, and then 10ml of saturated NaCl is added to the reaction solution. 2 S 2 o3 solution, the organic layer was washed with saturated NaCl solution (20ml*3), the organic layer was dried with anhydrous magnesium sulfate, filtered, the filtrate was concentrated under reduced pressure, and separated by column chromatography [eluent: dichloromethane: methanol: glacial acetic acid = 30 :1:1] to obtain 1.38g of white solid, that is, compound 2, with a yield of 31.6% and a liquid phase purity of 99.2%.

[0047] The...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicine synthesis, and concretely relates to a method for preparing a pitavastatin calcium epoxy impurity and a nitrogen oxide impurity. The method forpreparing the pitavastatin calcium epoxy impurity and the nitrogen oxide impurity comprises the following steps: oxidizing a raw material pitavastatin calcium by carbamide peroxide in the presence ofa catalyst to obtain the epoxy impurity and a compound 4, and processing the compound 4 under the action of sodium ethoxide to generate a sodium salt in order to obtain the nitrogen oxide impurity. The preparation method has the advantages of simplicity, reasonable route design and mild reaction conditions, and allows two oxidation products to be simultaneously obtained by using one oxidizing agent, and the prepared impurities have a high purity, and can be used for studying the quality of pitavastatin calcium as a reference substance for pitavastatin calcium impurity studying.

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical synthesis, and in particular relates to a preparation method of pitavastatin calcium epoxy impurities and nitrogen oxide impurities. Background technique [0002] Pitavastatin calcium is a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor that was launched in Japan in 2003 for the treatment of hypercholesterolemia. Because of its remarkable curative effect, it is called "super statin drugs". [0003] The chemical name of pitavastatin calcium is (+)-bis{(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5 -dihydroxy-6-heptenoic acid} calcium (compound 1), the double bond in the molecule and the nitrogen of the quinoline ring are easily oxidized to generate pitavastatin calcium epoxy impurity and nitrogen oxygen impurity respectively, namely (3R, 5S)-7-[2-cyclopropyl-4-(fluorophenyl) quinoline-3-yl]-3,5-dihydroxy-6,7-epoxyheptenoic acid (compound 2) and { (3R,5...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D405/04C07D215/60
CPCC07D405/04C07D215/60
Inventor 李宗涛张涛杨学谦孔令金孟凡领翟民郑亮
Owner SHANDONG QIDU PHARMA